Related Experiment Video
Updated: Aug 5, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Career Paths to Drug Development and Regulatory Science Through the U.S. Food and Drug Administration
Susan M Abdel-Rahman1, Gelareh Abulwerdi1, Issam Zineh1
1Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Room 3184, Building 51, Silver Spring, MD, 20993, USA.
Background:
Across the U.S., pharmacy students have limited access to education and experiential training in non-patient facing roles that support the drug development and regulatory sectors. As a result, few cite jobs in industry or government among their career goals after graduation. Advanced pharmacy practice experiences (APPE) have been demonstrated to inform decision making and enhance confidence in pursuing opportunities outside of traditional pharmacy practice settings.
Objective:
In this report, we discuss the career outcomes of students having participated in APPE within the Office of Clinical Pharmacology (OCP) at the U.S. Food and Drug Administration.
Methods:
Data on former rotation students' most recent roles and employment sectors were aggregated from May 2013 to January 2025. The analysis relied principally on internet searches focusing on professional and scientific networking platforms (e.g. LinkedIn®, ResearchGate), professional society membership directories, other social media content, or university experiential offices.
Results:
From 2013 to 2025, 199 students participated in the OCP rotation at the FDA. They came from 42 colleges and universities across 22 states and the District of Columbia with relative parity between public and private institutions (52% vs. 48%). Their most recent work sector was available for 182 participants. 51% of students were working in the pharmaceutical industry, 6% were in government, and 4% were consultants. 24% of students were working in healthcare.
Conclusion:
We observed entry into the drug development and regulatory sectors occurring at much higher rates in our graduates as compared with national surveys. Non-patient facing opportunities of public health relevance remain an important alternative to careers in community and hospital pharmacy. Ensuring sustained access to APPE in research & development, public policy, and regulatory affairs can contribute to the pipeline of competent and confident graduates who seek roles in drug development and regulatory science.
Related Concept Videos
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials: Overview
Drug Discovery: Overview
